Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02638766
Title Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications

gastrointestinal stromal tumor

Therapies

Regorafenib

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Institute Bergonie Recruiting Bordeaux France Details
Centre Leon Berard Recruiting Lyon France Details
Gustave Roussy Not yet recruiting Villejuif France Details
Fondazione IRCCS Istituto Dei Tumori di Milano Recruiting Milan Italy Details
Istituto Clinico Humanitas Milano Not yet recruiting Milan Italy Details
Policlinico Universitario Campus Bio-Medico Recruiting Roma Italy Details
Istituto di Candiolo - IRCSS Recruiting Torino Italy Details
Hospital Universitario de Canarias Recruiting La Laguna Santa Cruz De Tenerife 38320 Spain Details
Hospital de Cruces Recruiting Barakaldo 48902 Spain Details
Hospital Universitario Vall d´hebron Recruiting Barcelona 08035 Spain Details
Hospital de la Santa Creu i Sant Pau Recruiting Barcelona 08041 Spain Details
Hospital Universitario Gregorio Marañon Recruiting Madrid 28009 Spain Details
Hospital Universitario La Paz Recruiting Madrid 28046 Spain Details
Hospital Universitario Virgen del Rocío Recruiting Sevilla 41013 Spain Details
Hospital Universitario Virgen de la Macarena Recruiting Sevilla 41071 Spain Details
Instituto Valenciano de Oncología Recruiting Valencia 46009 Spain Details
Hospital Universitario Miguel Servet Recruiting Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field